Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 5
1962 3
1963 2
1964 5
1965 1
1966 3
1967 3
1968 8
1969 5
1970 4
1971 8
1972 5
1973 13
1974 15
1975 6
1976 8
1977 10
1978 11
1979 17
1980 14
1981 14
1982 11
1983 12
1984 19
1985 17
1986 11
1987 24
1988 42
1989 12
1990 36
1991 27
1992 26
1993 36
1994 40
1995 34
1996 42
1997 43
1998 31
1999 20
2000 17
2001 4
2002 10
2003 12
2004 12
2005 12
2006 12
2007 11
2008 12
2009 18
2010 10
2011 20
2012 21
2013 21
2014 16
2015 14
2016 8
2017 16
2018 26
2019 20
2020 22
2021 21
2022 22
2023 23
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

997 results

Results by year

Filters applied: . Clear all
Page 1
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era.
Goyal G, Heaney ML, Collin M, Cohen-Aubart F, Vaglio A, Durham BH, Hershkovitz-Rokah O, Girschikofsky M, Jacobsen ED, Toyama K, Goodman AM, Hendrie P, Cao XX, Estrada-Veras JI, Shpilberg O, Abdo A, Kurokawa M, Dagna L, McClain KL, Mazor RD, Picarsic J, Janku F, Go RS, Haroche J, Diamond EL. Goyal G, et al. Among authors: toyama k. Blood. 2020 May 28;135(22):1929-1945. doi: 10.1182/blood.2019003507. Blood. 2020. PMID: 32187362 Free article. Review.
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Miyazaki K, Sakai R, Iwaki N, Yamamoto G, Murayama K, Nishikori M, Sunami K, Yoshida I, Yano H, Takahashi N, Okamoto A, Munemoto S, Sawazaki A, Suehiro Y, Fukuhara N, Wake A, Arai A, Masaki Y, Toyama K, Yokoyama A, Tsunemine H, Hasegawa Y, Matsumoto K, Yamada T, Nishimura Y, Tamaru S, Asano N, Miyawaki K, Izutsu K, Kinoshita T, Suzuki R, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: toyama k. Cancer Sci. 2023 Jun;114(6):2689-2691. doi: 10.1111/cas.15784. Epub 2023 Mar 16. Cancer Sci. 2023. PMID: 36929591 Free PMC article. Clinical Trial. No abstract available.
[Biliary peritonitis].
Toyama K, Matsuda M. Toyama K, et al. Ryoikibetsu Shokogun Shirizu. 1996;(9):496-9. Ryoikibetsu Shokogun Shirizu. 1996. PMID: 8705545 Review. Japanese. No abstract available.
Diabetic Cardiovascular Disease Induced by Oxidative Stress.
Kayama Y, Raaz U, Jagger A, Adam M, Schellinger IN, Sakamoto M, Suzuki H, Toyama K, Spin JM, Tsao PS. Kayama Y, et al. Among authors: toyama k. Int J Mol Sci. 2015 Oct 23;16(10):25234-63. doi: 10.3390/ijms161025234. Int J Mol Sci. 2015. PMID: 26512646 Free PMC article. Review.
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016-2021).
Shibayama H, Itagaki M, Handa H, Yokoyama A, Saito A, Kosugi S, Ota S, Yoshimitsu M, Tanaka Y, Kurahashi S, Fuchida SI, Iino M, Shimizu T, Moriuchi Y, Toyama K, Mitani K, Tsukune Y, Kada A, Tamura H, Abe M, Iwasaki H, Kuroda J, Takamatsu H, Sunami K, Kizaki M, Ishida T, Saito T, Matsumura I, Akashi K, Iida S. Shibayama H, et al. Among authors: toyama k. Int J Hematol. 2024 Jun;119(6):707-721. doi: 10.1007/s12185-024-03754-8. Epub 2024 Mar 29. Int J Hematol. 2024. PMID: 38548963 Free PMC article.
Current status of antibody therapy for breast cancer.
Toi M, Takada M, Bando H, Toyama K, Yamashiro H, Horiguchi S, Saji S. Toi M, et al. Among authors: toyama k. Breast Cancer. 2004;11(1):10-4. doi: 10.1007/BF02967994. Breast Cancer. 2004. PMID: 14718785 Review.
997 results